Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
bioMerieux (BMXMF) had Free Cash Flow of $122.84M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$3.98B |
|
$387.03M |
|
$1.75B |
|
$2.23B |
|
$3.50B |
|
$475.24M |
|
$-1.84M |
|
$473.29M |
|
$473.29M |
|
$349.37M |
|
$349.37M |
|
$349.37M |
|
$349.37M |
|
$475.24M |
|
$711.61M |
|
118.15M |
|
118.15M |
|
$3.28 |
|
$3.26 |
|
| Balance Sheet Financials | |
$2.39B |
|
$1.47B |
|
$3.31B |
|
$5.69B |
|
$1.18B |
|
$384.65M |
|
$454.35M |
|
$1.63B |
|
$4.06B |
|
$2.73B |
|
$4.06B |
|
118.36M |
|
| Cash Flow Statement Financials | |
$482.06M |
|
$-529.03M |
|
$-132.37M |
|
$572.21M |
|
$360.84M |
|
$-211.37M |
|
$21.32M |
|
$-108.45M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.03 |
|
-- |
|
-- |
|
0.09 |
|
0.14 |
|
55.99% |
|
11.95% |
|
11.95% |
|
17.89% |
|
11.90% |
|
9.73% |
|
|
Free Cash Flow |
$122.84M |
-- |
|
-- |
|
-- |
|
0.70 |
|
1.78 |
|
3.89 |
|
93.80 |
|
8.60% |
|
12.79% |
|
6.14% |
|
7.86% |
|
$34.31 |
|
$1.04 |
|
$4.08 |
|